Highlights Essex Bio-Technology Limited

Equities

1061

KYG312371035

Delayed Hong Kong S.E. Other stock markets 04:57:55 16/05/2024 BST			5-day change	1st Jan Change
2.51 ^HKD	0.00%		+8.82%	+4.02%

03-19	Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover	MT
03-18	Essex Bio-Technology Limited Proposes Final Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable June 17, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover	03-19	MT
Essex Bio-Technology Limited Proposes Final Ordinary Dividend for the Financial Year Ended 31 December 2023, Payable June 17, 2024	03-18	CI
Essex Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
Essex Bio-Technology's Profit Jumps 22% in H1	17/08/23	MT
Essex Bio-Technology Limited Declares Interim Dividend for the Six Months Ended June 30, 2023, Payable on September 13, 2023	16/08/23	CI
Essex Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	16/08/23	CI
Essex Bio-Technology Limited Provides Update on the Phase 1/2 Clinical Study in Relation to the Co-Development of the Licensed Product with Henlius for the Treatment of Exudative Age-Related Macular Degeneration	26/07/23	CI
Essex Bio-Technology Limited commences an Equity Buyback Plan for 57,064,900 shares, representing 10% of its issued share capital, under the authorization approved on June 9, 2023.	13/06/23	CI
Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2022	09/06/23	CI
Essex Bio-Technology Limited's Equity Buyback announced on May 12, 2022 has expired.	08/06/23	CI
Essex Bio-Technology Slashes Final Dividend as 2022 Profit Falls	09/03/23	MT
Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2022, Payable on 29 June 2023	08/03/23	CI
Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.	08/03/23	CI
Essex Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	08/03/23	CI
Essex Bio-Technology Limited Completes First Patient First Dose in the United States in an International Multi-Centre Phase 3 Clinical Study	10/02/23	CI
Essex Bio-Technology Expects 35% Fall in 2022 Profit; Shares Slip 3%	11/01/23	MT
Essex Bio-Technology Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2022	10/01/23	CI
Essex Bio-Technology Limited Declares Interim Dividend for the Six Months Ended 30 June 2022, Payable on September 21, 2022	23/08/22	CI
Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.	23/08/22	CI
Essex Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2022	23/08/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Essex Bio-Technology Limited

Equities

1061

KYG312371035

Highlights

Filters